Surmodics, Inc

Surmodics, Inc. is a specialized medical device company focused on three core business segments: interventional endovascular products, performance coatings for intravascular medical devices, and in vitro diagnostic (IVD) chemical components. The company is a global leader in customized hydrophilic, hemocompatible, and drug-delivery surface coatings applied to complex intravascular devices for interventional cardiology, neurovascular, and peripheral vascular procedures. Surmodics manufactures and markets breakthrough endovascular thrombectomy and vascular access platforms, including the Pounce™ Thrombectomy Platform (for arterial and venous thrombi in vessels 2–16mm diameter range), Pounce™ Venous Thrombectomy System, and Sublime™ Radial Access Platform for radial-to-peripheral interventions. The company also provides Preside™ Hydrophilic Coatings for neuro, coronary, and peripheral device applications. As a Contract Development and Manufacturing Organization (CDMO), Surmodics offers end-to-end development and scalable manufacturing services for complex medical devices. In the IVD space, Surmodics supplies high-performance chemical components for immunoassay tests and microarray diagnostics, enabling signal amplification and noise reduction in diagnostic platforms. The company operates under FDA regulation, with products restricted to physician sale and use. Surmodics serves interventional radiologists, cardiologists, vascular surgeons, and diagnostic test manufacturers globally.